Singer, M. A., Wykoff, C. C., Riemann, C. D., Gonzalez, V. H., Weng, C. Y., Alkhatib, K., . . . Pao, M. (2026). Fluocinolone Acetonide Implant as a Baseline Therapy for Diabetic Macular Edema: Results from the Randomized Phase 4 NEW DAY Study. Ophthalmology, 133(7), 837. https://doi.org/10.1016/j.ophtha.2026.03.019
Chicago Style (17th ed.) CitationSinger, Michael A., Charles C. Wykoff, Christopher D. Riemann, Victor H. Gonzalez, Christina Y. Weng, Kamel Alkhatib, Rohit A. Amarshi, Scott Moody, and Mary Pao. "Fluocinolone Acetonide Implant as a Baseline Therapy for Diabetic Macular Edema: Results from the Randomized Phase 4 NEW DAY Study." Ophthalmology 133, no. 7 (2026): 837. https://doi.org/10.1016/j.ophtha.2026.03.019.
MLA (9th ed.) CitationSinger, Michael A., et al. "Fluocinolone Acetonide Implant as a Baseline Therapy for Diabetic Macular Edema: Results from the Randomized Phase 4 NEW DAY Study." Ophthalmology, vol. 133, no. 7, 2026, p. 837, https://doi.org/10.1016/j.ophtha.2026.03.019.